← Evidence map

ArticleProblemy endokrinologii2022

[Imeglimin: features of the mechanism of action and potential benefits].

K O Kuznetsov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2022
2023
2024
2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35841169